Intrinsic Value of S&P & Nasdaq Contact Us

CME Group Inc. CME NASDAQ

NASDAQ Global Select • Financial Services • Financial - Data & Stock Exchanges • US • USD

SharesGrow Score
75/100
5/7 Pass
SharesGrow Intrinsic Value
$271.54
-8.6%
Analyst Price Target
$311.83
+5%

CME Group Inc. (CME) is a Financial - Data & Stock Exchanges company in the Financial Services sector, currently trading at $297.03. It has a SharesGrow Score of 75/100, indicating a strong investment profile with 5 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of CME = $271.54 (-8.6% from the current price, the stock appears fairly valued). Analyst consensus target is CME = $312 (+5% upside).

Valuation: CME trades at a trailing Price-to-Earnings (P/E) of 26.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 5.64.

Financials: revenue is $6.5B, +9.1%/yr average growth. Net income is $4.0B, growing at +14.6%/yr. Net profit margin is 62% (strong). Gross margin is 86.1% (+1.1 pp trend).

Balance sheet: total debt is $3.8B against $28.7B equity (Debt-to-Equity (D/E) ratio 0.13, conservative). Current ratio is 92.97 (strong liquidity). Debt-to-assets is 1.9%. Total assets: $198.5B.

Analyst outlook: 13 / 35 analysts rate CME as buy (37%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 33/100 (Fail), Growth 73/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 82/100 (Pass), Future 40/100 (Partial), Income 100/100 (Pass).

$311.83
▲ 4.98% Upside
Average Price Target
Based on 35 Wall Street analysts offering 12-month price targets for CME Group Inc., the average price target is $311.83, with a high forecast of $340.00, and a low forecast of $300.00.
Highest Price Target
$340.00
Average Price Target
$311.83
Lowest Price Target
$300.00

CME SharesGrow Score Overview

75/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 33/100
Valuation — P/E, PEG, Forward PEG
GROWTH 73/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 82/100
Gross margin is + market cap
FUTURE 40/100
Analyst outlook — as buy
INCOME 100/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CME

VALUE Fail
33/100
CME trades at a trailing Price-to-Earnings (P/E) of 26.6 (S&P 500 average ~25). Forward PEG 5.64 — overvalued. Trailing PEG 3.23. Analyst consensus target is $312, implying +5% from the current price $297. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
73/100
CME: +9.1%/yr revenue is, +14.6%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
CME: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet CME: Debt-to-Equity (D/E) ratio 0.13 (conservative), Current ratio is 92.97 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Pass
82/100
CME: Gross margin is 86.1% (+1.1 pp trend), $107B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 82/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
40/100
Analyst outlook: 13 / 35 analysts rate CME as buy (37%). Analyst consensus target is $312 (+5% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Pass
100/100
CME: Net profit margin is 62%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range248.53-329.16
Volume1.65M
Avg Volume (30D)2.3M
Market Cap$106.52B
Beta (1Y)0.30
Dividend Yield$5.2000
Share Statistics
EPS (TTM)11.18
Shares Outstanding$359.63M
IPO Date2002-12-06
Employees3,760
CEOTerrence A. Duffy
Financial Highlights & Ratios
Revenue (TTM)$6.52B
Gross Profit$5.61B
EBITDA$5.72B
Net Income$4.04B
Operating Income$4.23B
Total Cash$4.55B
Total Debt$3.76B
Net Debt$-666.2M
Total Assets$198.55B
Price / Earnings (P/E)26.6
Price / Sales (P/S)16.34
Analyst Forecast
1Y Price Target$308.50
Target High$340.00
Target Low$300.00
Upside+3.9%
Rating ConsensusHold
Analysts Covering35
Buy 37% Hold 49% Sell 14%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS12572Q1058

Price Chart

CME
CME Group Inc.  ·  NASDAQ Global Select
Financial Services • Financial - Data & Stock Exchanges
248.53 52WK RANGE 329.16
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message